Henry J. Fuchs - President, Worldwide R&D at Biomarin Pharmaceutical Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Worldwide R&D
Stock Symbol
BMRN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Henry J. Fuchs - trading volume in the past year for Biomarin Pharmaceutical Inc

Holdings reported by Henry J. Fuchs for Biomarin Pharmaceutical Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 196,872 $16.5 M $83.87 Mar 15, 2024 Direct
Stock Option (Right to Buy Common Stock) 40,860 Mar 15, 2024 Direct Common Stock

Transactions reported by Henry J. Fuchs for Biomarin Pharmaceutical Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership